OrbiMed Advisors Israel II Ltd
10% Owner; Director, 10% Owner · 2 filings · Latest: Sep 28, 2026
ADARx Pharmaceuticals, Inc.
Adicet Bio, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ADRX | OrbiMed Advisors Israel II Ltd | Director, 10% Owner | Sep 28, 2026 | Purchase | $17.00 | 950,000 | $16.1M | 588,235 | |
ACET | OrbiMed Advisors Israel II Ltd | 10% Owner | Apr 8, 2026 | Sale | $6.42 | 72,939 | $468.1K | 0 | |
ACET | OrbiMed Advisors Israel II Ltd | 10% Owner | Apr 7, 2026 | Sale | $6.52 | 31,719 | $206.8K | 32,523 | |
ACET | OrbiMed Israel Partners II, L.P. | — | Apr 8, 2026 | Proposed Sale | $6.55 | 40,416 | $264.7K | — |